Gynecomastia Medical Services in China

Gynecomastia is a benign condition characterized by the enlargement of glandular breast tissue in males, often resulting from hormonal imbalances—particularly an elevated estrogen-to-androgen ratio—during puberty, aging, or due to medications, obesity, endocrine disorders, or idiopathic causes. While typically non-life-threatening, it can cause significant psychological distress, social anxiety, and body image concerns, prompting many patients to seek surgical correction. The standard treatment for persistent or symptomatic gynecomastia is surgical excision of glandular tissue, often combined with liposuction for contour refinement. Outcomes are generally excellent, with high patient satisfaction rates when performed by experienced plastic surgeons using tailored techniques such as periareolar incisions and ultrasonic-assisted liposuction.

China offers compelling advantages for international patients seeking gynecomastia surgery: competitive pricing (30–50% lower than the U.S. or Western Europe), minimal wait times, state-of-the-art facilities accredited by JCI or CNAS, and surgeons trained in both Western and Asian aesthetic principles—emphasizing natural contours and minimal scarring. Chinese plastic surgery centers in Beijing, Shanghai, and Guangzhou routinely perform over 2,000 gynecomastia procedures annually, with published success rates exceeding 95% and complication rates under 2%. Notable cases include multinational athletes and professionals who achieved symmetrical, athletic chest contours within 4–6 weeks postoperatively—demonstrating China’s integration of precision technique, rapid recovery protocols, and comprehensive pre- and post-operative care.

Treatment Options & Itemized Cost Breakdown: Gynecomastia (Plastic Surgery Department)

Non-Surgical / Conservative Management

*Indicated for mild, recent-onset (<12 months), or pubertal gynecomastia with confirmed hormonal imbalance or medication-induced cause.*

• •Endocrine evaluation & lab testing: Serum testosterone, estradiol, LH, FSH, prolactin, liver/kidney function — $85–$120
• •Pharmacotherapy (3–6 months):

- *Aromatase inhibitors (e.g., anastrozole)*: $90–$130/month (imported brand)

• •Lifestyle & monitoring: Nutrition counseling, weight management, drug review — $30–$50/session (3 sessions typical)
• •Total conservative pathway (6 months): $280–$520

Surgical Intervention

*Eligibility: Persistent >12 months, Grade II–III gynecomastia (excess glandular tissue ± skin laxity), BMI <30, no active endocrine malignancy, stable comorbidities.*

• •Preoperative workup: ECG, chest X-ray, coagulation panel, breast ultrasound — $110–$160
• •Surgical options (all performed in Plastic Surgery Department):

- *Excision + liposuction (Grade II–III, glandular/hybrid)*: $2,300–$3,600 - *Excision + skin resection (Grade III with ptosis)*: $3,800–$5,200

• •Anesthesia: Local + sedation ($220–$350) or general ($480–$720) — included in surgical range above

Special/Complex Cases

• •*Recurrent gynecomastia post-surgery*: Revision excision + fat grafting for contour refinement — $4,100–$6,300
• •*Severe asymmetry or bilateral reconstruction*: Bilateral staged procedures with intraoperative ultrasound mapping — $5,500–$7,900
• •*Gynecomastia secondary to Klinefelter syndrome or chronic liver disease*: Requires multidisciplinary coordination (Endocrinology + Hepatology); pre-op hormonal optimization adds $220–$380

Quick Selection Guide

• •Adolescents (13–17 y/o, recent onset): Start with conservative management + 6-month observation; optimal cost: $280–$520
• •Adults (18–45 y/o, Grade II, no comorbidities): Direct surgical intervention (excision + liposuction); optimal cost: $2,300–$3,600
• •Patients >45 y/o or with diabetes/hypertension: Mandatory pre-op cardiology clearance (+$180); proceed with excision + liposuction under monitored anesthesia — total $2,700–$4,100
• •Budget-constrained patients (<$2,000): Liposuction-only if ultrasound confirms <30% glandular component; cost: $1,450–$2,100
• •Severe skin excess (nipple at or below inframammary fold): Excision + skin resection is mandatory; minimum $3,800